INTRODUCTION {#sec1-1}
============

Microbial diseases remain an important health issue in human communities which has been targeted by the efforts of many researchers in medical, health, and laboratory areas. Despite development of different antibiotics, the problem of microbial resistance to the antibiotics highlights the necessity of seeking out new antimicrobial compounds.\[[@ref1]\] According to evidence on emergence of resistance in microorganisms to antibiotics, use of antimicrobial plant-based compounds has further increased in the recent years.\[[@ref1]\]

Despite confirmed antimicrobial effects of medicinal plants and nature-based compounds, use of them to treat infections has not become common and physicians continue to prescribe chemical antibiotics. Many medicinal plants are being used to treat microbial diseases.\[[@ref2][@ref3][@ref4][@ref5]\]

*Carum copticum* is from family *Apiaceae*. *C. copticum* is originally from Asia and spontaneously occurs or is cultivated in India, Iran, and Egypt. This plant is annual and its seeds are usable.\[[@ref6][@ref7][@ref8]\] Phytochemical studies have demonstrated that over 85% of the compounds of *C. copticum* essential oil are thymol, gamma-terpinene, and paracymene. Thymol can exert hypotensive effects and be used to treat skin diseases such as acne, psoriasis, and dermatitis in combination with other phenolic compounds.\[[@ref9]\] Gamma-terpinene is used in perfume industry and paracymene is used in perfume and pharmaceutical industries as they can help different drugs be absorbed through skin pores and have antibacterial and antifungal effects. *C. copticum* fruit extract can be used to heal wounds.\[[@ref10]\] Besides that, *C. copticum* fruit has been reported to exert anti-nausea and antifungal effects.\[[@ref10]\]

Peppermint, botanically called *Mentha piperita* L., is from family *Lamiaceae*. *M. piperita* is a medicinal and fragrant plant whose essential oil has many pharmaceutical, food, and cosmetic uses. *M. piperita* is a herbaceous and perennial plant and has creeping and underground stems, the stem is rectangular and purplish red, the leaves are elliptical, and positioned as crossed on the stem. The flowers are purple and the fruit is red and capsule-shaped, and has a nongerminative seed.\[[@ref11]\] The compounds of *M. piperita* essential oil have antioxidant, fungicidal, and insecticidal effects.\[[@ref12][@ref13][@ref14]\] The antimicrobial effects of *C. copticum* on *Candida albicans*, *Escherichia coli*, and *Staphylococcus aureus* have been confirmed.\[[@ref15]\] In addition, it has been demonstrated that *M. piperita* essential oil causes elimination of any Salmonella species\[[@ref16]\] and exerts inhibitory effects on C. albicans.\[[@ref17]\] Analysis of *M. piperita* essential oil has indicated that this plant contains ethyl ether, acetic acid, isomenthol, polygon, neomenthol, menthol, piperitone, and neoisomenthol.\[[@ref18]\] However, a more important argument is concerned with reduction in the side effects and toxic effects of antibiotics in patients and antibiotic resistance.

Therefore, in this experimental study, the synergistic effects of *C. copticum* and *M. piperita* essential oils with antibiotics on *S. aureus* (ATCC 25923), *Enterococcus faecalis* (ATCC 29212), *E. coli* (ATCC 8739), *Pseudomonas aeruginosa* (ATCC 9027), *Staphylococcus epidermidis* (ATCC 14990), and *Listeria monocytogenes* (ATCC 7644) were studied according to broth microdilution.

MATERIALS AND METHODS {#sec1-2}
=====================

Preparation of medicinal plants and antibiotics {#sec2-1}
-----------------------------------------------

*C. copticum* and *M. piperita* were provided from Darab, Fars province. [Table 1](#T1){ref-type="table"} shows botanical characteristics of these two plants.

###### 

Botanical characteristics of *Carum copticum* and *Mentha Piperita*
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*C. copticum* and *M. piperita* essential oils were purchased from a pharmaceutical company (Saghar Darab Fars) and assessed by broth microdilution.

Preparation of essential oils {#sec2-2}
-----------------------------

The essential oil initial concentration was 850 μg/1000 ml. The resulting substance was first dissolved in 0.5 ml hexane and diluted with phosphate buffered saline at 1:5 or 1:20 rate. Before tests of minimum bacteriostatic concentration (MIC) and minimum bactericidal concentration (MBC), the essential oils were sterilized by passing through a 0.22-μm filter (Jet Bio-Filtration Co., China). The densities of the essential oils were determined manually through calculation of the essential oil\'s mass and volume as well as by densitometer (the mean pure density of the essential oil was determined 850 μg/ml). Different purities of a number of antibiotics (vancomycin, gentamicin, and ciprofloxacin \[Sigma, USA\]) were also assessed both in combination with the essential oils and separately as controls and the synergistic effects were investigated by determination of the MBC and MIC. Each experiment was conducted in triplicate and the mean values were included in data analysis.

Preparation of the studied bacteria {#sec2-3}
-----------------------------------

### Broth microdilution {#sec3-1}

To prepare microbial suspension, 24-h culture was prepared from each bacterium. The bacteria were inoculated on nutrient agar culture medium and then incubated for 24 h. To do this, the 24-h culture of the bacteria on Mueller-Hinton agar medium was introduced into normal saline and an opacity equal to 0.5 McFarland developed with an approximately 1.5 × 108 CFU/ml bacteria in the suspension.\[[@ref19]\]

Determining MIC {#sec2-4}
---------------

In this study, the MIC was tested according to the method recommended by the National Committee for Clinical Laboratory Standards in a 96-well sterile plate according to the broth microdilution method. First, 100 μl of Mueller-Hinton broth culture medium (Merck, Germany) was introduced into 96-well microplate. Then, 100 μl of the essential oil was added to the first wall in each row and dilution was conducted in 2^nd^--9^th^ wells. The dilution in each well was determined and registered in view of the essential oil\'s volume and density. Finally, 100 μl of the microbial suspension was added to all wells and their opacity was investigated by tray reading stand plate base after 24-h incubation at 37°C for 24 h. The concentration of the last (most diluted) well with no opacity was considered MIC.

Determining minimum bactericidal concentration {#sec2-5}
----------------------------------------------

To investigate the MBC, all wells without opacity were cultured on Mueller-Hinton broth culture medium, and after 24-h incubation, the lowest concentration of the essential oil in which the bacteria did not grow (decrease in CFU by 99.9% lower than the control) was reported to be the MBC.

Determining synergistic effect {#sec2-6}
------------------------------

In determining the MIC and the MBC, the concentration of the essential oil or antibiotic was decided to be 0.25--25 μg/ml according to the purity percentage of the antibiotic and then dilution serially conducted. Afterward, 50 μl of each dilution was poured into the next wall (perpendicular to the direction of serial dilution) such that each well contained 50 μl of the essential oil and 50 μl of the antibiotic instead of 100 μl of the essential oil and 100 μl of the antibiotic, respectively.

By this way, in the 96-well plate, the essential oil and antibiotics at different dilutions were combined with each other. After addition of 100 μl of the microbial suspension as described above, the dilutions of the MIC and MBC of the antibiotics, essential oil, and their combination were determined. Then, the fractional inhibitory concentration (FIC) was computed as follows:

The combination\'s MIC was divided by the antibiotic\'s MIC. If the result was lower than 0.5, the two compounds had synergistic effect, if it was 0.5--1, the effect was additive, if it was 1--4, combination of them was considered to have no effect, and if it was ≥4, the effect of the two compounds was considered to be antagonist.\[[@ref20]\]

Data analysis {#sec2-7}
-------------

The findings on antibiotics were registered in the tables of the MIC, MBC, and FIC. The experiments were conducted in triplicate and the mean values were included in the data analysis.

RESULTS {#sec1-3}
=======

In this study, the synergistic effects of *C. copticum* and *M. piperita* essential oils on a number of pathogenic bacteria were investigated. The method of the experiments was broth microdilution, the experiments were conducted in triplicate, and the mean values of the three experiments\' results are shown in Tables [2](#T2){ref-type="table"}--[11](#T11){ref-type="table"}.

###### 

Mean (standard deviation) minimum inhibitory concentration and minimum bactericidal concentration (μg/ml) of *Carum copticum* and combination of *Carum copticum* and vancomycin for *Enterococcus faecalis*
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###### 

Mean (standard deviation) minimum inhibitory concentration and minimum bactericidal concentration (μg/ml) of *Carum copticum* essential oil and combination of *Carum copticum* essential oil and ciprofloxacin for *Escherichia coli*
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###### 

Mean (standard deviation) minimum inhibitory concentration and minimum bactericidal concentration (μg/ml) of *Carum copticum* essential oil and combination of *Carum copticum* essential oil and vancomycin for *Staphylococcus aureus*
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###### 

Mean (standard deviation) minimum inhibitory concentration and minimum bactericidal concentration (μg/ml) of *Carum copticum* essential oil and combination of *Carum copticum* essential oil and ciprofloxacin for *Staphylococcus epidermidis*
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###### 

Mean (standard deviation) minimum inhibitory concentration and minimum bactericidal concentration (μg/ml) of *Carum copticum* essential oil and combination of *Carum copticum* essential oil and gentamicin for *Pseudomonas aeruginosa*
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###### 

Mean (standard deviation) minimum inhibitory concentration and minimum bactericidal concentration (μg/ml) of *Carum copticum* essential oil and combination of *Carum copticum* essential oil and ciprofloxacin for *Listeria monocytogenes*
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###### 

Mean (standard deviation) minimum inhibitory concentration and minimum bactericidal concentration (μg/ml) of *Mentha piperita* essential oil and combination of *Mentha piperita* essential oil and vancomycin for *Enterococcus faecalis*
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###### 

Mean (standard deviation) minimum inhibitory concentration and minimum bactericidal concentration (μg/ml) of *Mentha piperita* essential oil and combination of *Mentha piperita* essential oil and ciprofloxacin for *Escherichia coli*
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###### 

Mean (standard deviation) minimum inhibitory concentration and minimum bactericidal concentration (μg/ml) of *Mentha piperita* essential oil and combination of *Mentha piperita* essential oil and ciprofloxacin for *Staphylococcus epidermidis*
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###### 

Mean (standard deviation) minimum inhibitory concentration and minimum bactericidal concentration (μg/ml) of *Mentha piperita* essential oil and combination of *Mentha piperita* essential oil and vancomycin for *Staphylococcus aureus*
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In this study, the synergistic effect of *C. copticum* with vancomycin on *E. faecalis* was investigated and the FIC was derived three that represents lack of effect of the combination of these two compounds \[[Table 2](#T2){ref-type="table"}\].

The results demonstrated that 30 μg/ml of *C. copticum* could inhibit *E. coli* and combined with ciprofloxacin could decrease the MBC from 5 to 3.9 μg/ml and the MIC from 3.6 to 0.6 μg/ml, and the FIC was 0.6 that represents lack of effect of the combination of these two compounds on *E. coli* growth \[[Table 3](#T3){ref-type="table"}\].

Moreover, the results demonstrated that 30 μg/ml of *C. copticum* could inhibit *S. aureus* growth and combined with vancomycin could decrease the MIC from 0.5 to 0.12 μg/ml, and it displayed a potent inhibitory effect on *S. aureus* growth such that the FIC was derived 0.24 that is very high \[[Table 4](#T4){ref-type="table"}\].

The results demonstrated that 68 μg/ml of *C. copticum* could inhibit S. epidermidis growth and combined with ciprofloxacin could decrease the MBC from 4 to 1.6 μg/ml that can be considered a significant effect.

In addition, the synergistic effect of *C. copticum* with ciprofloxacin on S. epidermidis growth was studied and found to cause the MIC of 4 μg/ml to reach 16 μg/ml, which represents no synergistic effect \[[Table 5](#T5){ref-type="table"}\].

The results showed that 544 μg/ml of *C. copticum* essential oil displayed effect on *P. aeruginosa* growth and combined with gentamicin exerted no effect \[[Table 6](#T6){ref-type="table"}\].

*C. copticum* essential oil at 1088 μg/ml caused inhibition of L. monocytogenes and combined with ciprofloxacin had FIC of 3 that represents lack of effect on L. monocytogenes growth \[[Table 7](#T7){ref-type="table"}\].

*M. piperita* essential oil at 4200 μg/ml caused inhibition of *E. faecalis* and combined with vancomycin had FIC of 2 that represents lack of effect on *E. faecalis* growth \[[Table 8](#T8){ref-type="table"}\].

The results demonstrated that 128 μg/ml of *M. piperita* could inhibit *E. coli* growth and combined with ciprofloxacin caused increase in the MIC from 1 to 3 μg/ml. The combination FIC for *E. coli* was three that represents lack of effect on *E. coli* growth \[[Table 9](#T9){ref-type="table"}\].

The results demonstrated that 212 μg/ml of *M. piperita* could inhibit S. epidermidis growth and combined with ciprofloxacin displayed FIC of 3 that represents lack of effect on S. epidermidis growth \[[Table 10](#T10){ref-type="table"}\].

The results demonstrated that 85 μg/ml of *M. piperita* could inhibit *S. aureus* growth and combined with ciprofloxacin displayed FIC of 2 that represents lack of effect on *S. aureus* growth \[[Table 11](#T11){ref-type="table"}\].

Unfortunately, it was not possible to investigate such effects on other bacteria, especially resistant ones. These effects should be investigated on a greater number of bacteria especially Gram-negative ones so that the findings may be inclusive enough to be used in clinical trials. Besides that, the synergistic effect should be investigated with novel antibiotics suitable for each bacterium such as third- and fourth-generation cephalosporins. However, the current study is considered a preliminary work.

DISCUSSION {#sec1-4}
==========

The antibacterial properties of *C. copticum* and *M. piperita* have already been confirmed. According to the experiments\' results in the current study, *C. copticum* and *M. piperita* have antibacterial properties such that *M. piperita* essential oil at 85 μg/ml dilution could inhibit *S. aureus* growth. *C. copticum* at 30 and 68 μg/ml could inhibit the growth of *S. aureus* and S. epidermidis, respectively. Briefly, the antibacterial effects of these two essential oils were more potent on *S. aureus*, and the antibacterial effect of *C. copticum* essential oil was more potent than that of *M. piperita* on the same bacteria.

In this study, the synergistic effects of *C. copticum* and *M. piperita* essential oils with antibiotics on a number of bacteria were investigated. The findings demonstrated that *C. copticum* essential oil had a potent antibacterial effect and displayed a relatively potent synergistic effect with vancomycin (FIC = 0.24). *M. piperita* essential oil displayed no synergistic effect with the studied antibiotics on S. epidermidis, *S. aureus*, *E. coli*, and *E. faecalis*. A study on the synergistic effect of some plant-based essential oils with antibiotics demonstrated that *M. piperita* essential oil had no synergistic effect with ampicillin, erythromycin, and gentamicin (FIC = 1 for all).\[[@ref21]\] The current study demonstrated that *M. piperita* exerted no synergistic effect with ciprofloxacin and vancomycin (FIC: 2--3). In our study, an approximately similar FIC was derived for *C. copticum* essential oil synergistic effect with vancomycin on *S. aureus* growth.

The findings of an experimental study demonstrated that Cuminum cyminum exerted synergistic effect with gentamicin on food-borne microorganisms according to disk diffusion method.\[[@ref22]\] In the present study, *C. copticum* synergistic effect with gentamicin on *P. aeruginosa* was investigated by broth microdilution and no effect was seen with FIC of 2. Fadli *et al*.\'s study on synergistic effects of 80 compounds of *Thymus vulgaris* essential oil with common antibiotics concluded that 71% of this plant\'s compounds displayed synergistic effect, 20% displayed relatively synergistic effect, and 9% displayed no effect on the studied bacteria.

In that study, *T. vulgaris* essential oil synergistic effect with ciprofloxacin on *E. coli* was found to have FIC of 0.12. In the current experimental study, the synergistic effects of *C. copticum* essential oil and *M. piperita* essential oil with ciprofloxacin on *E. coli* were found to have FIC of 0.6 and 3, respectively, which is in disagreement with Fadlie *et al*.\'s study. This inconsistency in the findings can be due to difference in the percentages the chemical compounds among the essential oils.\[[@ref23]\] In addition, Fadlie *et al*. reported that the synergistic effect of *T. vulgaris* essential oil with ciprofloxacin on *S. aureus* had an FIC of 0.26, but in the current study, *M. piperita* essential oil was found to have no synergistic effect with ciprofloxacin. A study investigated the synergistic effect of *Chrysanthemum indicum* with ampicillin and gentamicin on the growth of some species of bacteria using broth microdilution and concluded that *C. copticum* essential oil combined with ampicillin could decrease MIC of *E. coli*, *S. aureus*, and S. epidermidis by 1:2--1:6 but did not display synergistic effect (FIC of 0.5--1).\[[@ref24]\]

In this study, *C. copticum* essential oil exerted synergistic effect with gentamicin on *S. aureus* such that the MIC decreased from 3.2 to 2.0 μg/ml and FIC was 0.25 that represented their synergistic effect. In the current study, *C. copticum* essential oil exerted synergistic effect with vancomycin on *S. aureus*, which can be due to *S. aureus* susceptibility to the compounds in the plant-based essential oils that needs further research.

CONCLUSIONS {#sec1-5}
===========

*C. copticum* can exert a potent antibacterial effect that can cause a significant synergistic effect if accompanied by the antibiotics. In this study, it was demonstrated that *C. copticum* essential oil exerted synergistic effect with vancomycin. It is expected that these plant-based essential oils alongside antibiotics be incorporated into health-care system through further studies so that their useful effects can be used to fight drug resistance or to lower dosage or toxicity of the drugs.

Financial support and sponsorship {#sec2-8}
---------------------------------

Nil.

Conflicts of interest {#sec2-9}
---------------------

There are no conflicts of interest.
